Archive - July 2019
Eli Lilly announces Verzenio survival benefit
Neuraxpharm launches first products in UK
Biodesix, Immodulon team up for pancreatic cancer treatment
Bayer taps Sensyne Health AI and real world data for cardiovascular research
Mega-mergers dominate as buoyant markets lift biopharma
Confusing Burnout With Compassion Fatigue Has Its Dangers
Triplet approvals for myeloma boost Celgene in Q2
Bayer bags FDA nod for early prostate cancer drug darolutamide